Orthopedic M&A activity is on track for a historically low year. We discuss the slowdown, highlight companies making moves and provide an outlook for the remainder of 2024.
We break down funding announcements for the first half of 2024, make predictions for the remainder of the year and highlight companies receiving capital.
ASCs play an increasingly important role in orthopedic companies’ strategies as they seek to capitalize on the growing number of procedures shifting to outpatient settings.